117 related articles for article (PubMed ID: 4005851)
1. Specificity and inducibility of the metabolic reduction of chromium(VI) mutagenicity by subcellular fractions of rat tissues.
Petrilli FL; Camoirano A; Bennicelli C; Zanacchi P; Astengo M; De Flora S
Cancer Res; 1985 Jul; 45(7):3179-87. PubMed ID: 4005851
[TBL] [Abstract][Full Text] [Related]
2. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.
De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A
Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary metabolism of mutagens and its relationship with lung cancer and smoking habits.
De Flora S; Petruzzelli S; Camoirano A; Bennicelli C; Romano M; Rindi M; Ghelarducci L; Giuntini C
Cancer Res; 1987 Sep; 47(17):4740-5. PubMed ID: 3621172
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of mutagens and carcinogens in woodchuck liver and its relationship with hepatitis virus infection.
De Flora S; Camoirano A; Romano M; Astengo M; Cesarone CF; Millman I
Cancer Res; 1987 Aug; 47(15):4052-8. PubMed ID: 3607750
[TBL] [Abstract][Full Text] [Related]
5. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
[TBL] [Abstract][Full Text] [Related]
6. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation and deactivation of mutagens and carcinogens.
De Flora S
Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
[TBL] [Abstract][Full Text] [Related]
8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of cytochrome P450-inducers on promutagen activation capabilities and enzymatic activities of S-9 from rat liver.
Ong T; Mukhtar M; Wolf CR; Zeiger E
J Environ Pathol Toxicol; 1980 Aug; 4(1):55-65. PubMed ID: 7441130
[TBL] [Abstract][Full Text] [Related]
10. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
Hales BF
Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
[TBL] [Abstract][Full Text] [Related]
11. Selective induction of gene expression in rat lung by hexavalent chromium.
Izzotti A; Cartiglia C; Balansky R; D'Agostini F; Longobardi M; De Flora S
Mol Carcinog; 2002 Oct; 35(2):75-84. PubMed ID: 12325037
[TBL] [Abstract][Full Text] [Related]
12. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9.
Johnson TE; Umbenhauer DR; Galloway SM
Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047
[TBL] [Abstract][Full Text] [Related]
13. Enzyme specificity in the metabolic activation of N-nitrosodimethylamine to a mutagen for Chinese hamster V79 cells.
Yoo JS; Yang CS
Cancer Res; 1985 Nov; 45(11 Pt 1):5569-74. PubMed ID: 4053031
[TBL] [Abstract][Full Text] [Related]
14. Chromium(VI)-induced DNA lesions and chromium distribution in rat kidney, liver, and lung.
Tsapakos MJ; Hampton TH; Wetterhahn KE
Cancer Res; 1983 Dec; 43(12 Pt 1):5662-7. PubMed ID: 6640521
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke.
Petrilli FL; Rossi GA; Camoirano A; Romano M; Serra D; Bennicelli C; De Flora A; De Flora S
J Clin Invest; 1986 Jun; 77(6):1917-24. PubMed ID: 2423559
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens.
De Flora S; Bennicelli C; Zanacchi P; Camoirano A; Morelli A; De Flora A
Carcinogenesis; 1984 Apr; 5(4):505-10. PubMed ID: 6368036
[TBL] [Abstract][Full Text] [Related]
17. Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved?
Aiyar J; De Flora S; Wetterhahn KE
Carcinogenesis; 1992 Jul; 13(7):1159-66. PubMed ID: 1379126
[TBL] [Abstract][Full Text] [Related]
18. Oral chromium(VI) does not affect the frequency of micronuclei in hematopoietic cells of adult mice and of transplacentally exposed fetuses.
De Flora S; Iltcheva M; Balansky RM
Mutat Res; 2006 Nov; 610(1-2):38-47. PubMed ID: 16872865
[TBL] [Abstract][Full Text] [Related]
19. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
Buckpitt AR; Bahnson LS; Franklin RB
J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
[TBL] [Abstract][Full Text] [Related]
20. Binding of chromium to chromatin and DNA from liver and kidney of rats treated with sodium dichromate and chromium(III) chloride in vivo.
Cupo DY; Wetterhahn KE
Cancer Res; 1985 Mar; 45(3):1146-51. PubMed ID: 2578874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
